English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Familial hypercholesterolemia (FH) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels and increased cardiovascular disease (CVD) risk. FH patients often have increased lipoprotein(a) [Lp(a)] levels, which further increase CVD risk. Novel methods for accurately calculating LDL-C have been proposed.    Methods  Patients with FH were recruited by a network of Greek sites participating in the HELLAS-FH registry. LDL-C levels were calculated using the Friedewald (LDL-C F ) and the Martin/Hopkins (LDL-C M/H ) equations as well as after correcting LDL-C M/H  for Lp(a) levels [LDL-C Lp(a)corM/H ]. The objective was to compare LDL-C levels and target achievement as estimated by different methods in FH patients.    Results  This analysis included 1620 patients (1423 adults and 197 children). In adults at diagnosis, LDL-C F  and LDL-C M/H  levels were similar [235 ± 70 mg/dL (6.1 ± 1.8 mmol/L) vs 235 ± 69 mg/dL (6.1 ± 1.8 mmol/L), respectively;  P  = NS], while LDL-C Lp(a)corM/H  levels were non-significantly lower than LDL-C F  [211 ± 61 mg/dL (5.5 ± 1.6 mmol/L);  P  = 0.432]. In treated adults ( n  = 966) both LDL-C F  [150 ± 71 mg/dL (3.9 ± 1.8 mmol/L)] and LDL-C M/H  levels [151 ± 70 mg/dL (6.1 ± 1.8 mmol/L);  P  = 0.746] were similar, whereas LDL-C Lp(a)corM/H  levels were significantly lower than LDL-C F  [121 ± 62 mg/dL (3.1 ± 1.6 mmol/L);  P  < 0.001]. Target achievement as per latest guidelines in treated patients using the LDL-C M/H  (2.5%) and especially LDL-C Lp(a)corM/H  methods (10.7%) were significantly different than LDL-C F  (2.9%;  P  < 0.001).  In children, all 3 formulas resulted in similar LDL-C levels, both at diagnosis and in treated patients. However, target achievement by LDL-C F  was lower compared with LDL-C M/H  and LDL-C Lp(a)corM/H  methods (22.1 vs 24.8 vs 33.3%;  P  < 0.001 for both comparisons).    Conclusion  LDL-C Lp(a)corM/H  results in significantly lower values and higher target achievement rate in both treated adults and children. If validated in clinical trials, LDL-C Lp(a)corM/H  may become the method of choice to more accurately estimate ‘true’ LDL-C levels in FH patients.

lipids in health and disease

Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry